Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

939 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
2018 update of the EULAR recommendations for the management of Behçet's syndrome.
Hatemi G, Christensen R, Bang D, Bodaghi B, Celik AF, Fortune F, Gaudric J, Gul A, Kötter I, Leccese P, Mahr A, Moots R, Ozguler Y, Richter J, Saadoun D, Salvarani C, Scuderi F, Sfikakis PP, Siva A, Stanford M, Tugal-Tutkun I, West R, Yurdakul S, Olivieri I, Yazici H. Hatemi G, et al. Among authors: gul a. Ann Rheum Dis. 2018 Jun;77(6):808-818. doi: 10.1136/annrheumdis-2018-213225. Epub 2018 Apr 6. Ann Rheum Dis. 2018. PMID: 29625968
Familial aggregation of Behçet's disease in Turkey.
Gül A, Inanç M, Ocal L, Aral O, Koniçe M. Gül A, et al. Ann Rheum Dis. 2000 Aug;59(8):622-5. doi: 10.1136/ard.59.8.622. Ann Rheum Dis. 2000. PMID: 10913059 Free PMC article.
Clinical course of ocular Behçet's disease in siblings.
Onal S, Tugal-Tutkun I, Urgancioglu M, Gul A. Onal S, et al. Among authors: gul a. Ocul Immunol Inflamm. 2001 Jun;9(2):111-24. doi: 10.1076/ocii.9.2.111.3971. Ocul Immunol Inflamm. 2001. PMID: 11449327
Anti-TNF therapy in the management of Behcet's disease--review and basis for recommendations.
Sfikakis PP, Markomichelakis N, Alpsoy E, Assaad-Khalil S, Bodaghi B, Gul A, Ohno S, Pipitone N, Schirmer M, Stanford M, Wechsler B, Zouboulis C, Kaklamanis P, Yazici H. Sfikakis PP, et al. Among authors: gul a. Rheumatology (Oxford). 2007 May;46(5):736-41. doi: 10.1093/rheumatology/kem034. Epub 2007 Apr 2. Rheumatology (Oxford). 2007. PMID: 17403712 Review. No abstract available.
Pro-inflammatory cellular immune response in Behçet's disease.
Kulaber A, Tugal-Tutkun I, Yentür SP, Akman-Demir G, Kaneko F, Gül A, Saruhan-Direskeneli G. Kulaber A, et al. Among authors: gul a. Rheumatol Int. 2007 Oct;27(12):1113-8. doi: 10.1007/s00296-007-0367-9. Epub 2007 Jun 5. Rheumatol Int. 2007. PMID: 17549482
EULAR recommendations for the management of Behçet disease.
Hatemi G, Silman A, Bang D, Bodaghi B, Chamberlain AM, Gul A, Houman MH, Kötter I, Olivieri I, Salvarani C, Sfikakis PP, Siva A, Stanford MR, Stübiger N, Yurdakul S, Yazici H; EULAR Expert Committee. Hatemi G, et al. Among authors: gul a. Ann Rheum Dis. 2008 Dec;67(12):1656-62. doi: 10.1136/ard.2007.080432. Epub 2008 Jan 31. Ann Rheum Dis. 2008. PMID: 18245110
939 results